Ratnakar Lavu - Mar 1, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & Chief Digital Officer
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:28 PM
Previous filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Award $0 +1.75K $0.00 1.75K Mar 1, 2024 Direct F1
transaction ELV Common Stock Award $0 +1K +57.13% $0.00 2.76K Mar 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +6.77K $0.00 6.77K Mar 1, 2024 Common Stock 6.77K $499.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units. Restrictions lapse as follows: 584 shares on 3/1/2025, and 585 shares each on 3/1/2026 and 3/1/2027.
F2 Represents restricted share units. Restrictions lapse as follows: 501 shares each on 3/1/2025 and 3/1/2026.
F3 The option represents a right to purchase a total of 6,765 shares, and is exercisable in three annual installments of 2,255 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.